GovChime
Cancelled on SAM.gov

Assay Service for assessing ADME properties and in vivo PK properties with the selected vendor. ENAMINE US INC

Overview

Response deadline
9:00 AM EDT
Posted
September 18, 2026
Notice type
Combined Synopsis/Solicitation
Set-aside
No Set aside used
NAICS
424690: Other Chemical and Allied Products Merchant Wholesalers
Agency
Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH

Notice details

Office
NATIONAL INSTITUTES OF HEALTH OLAO
Place of performance
Bethesda, Maryland, 20892
Last updated
Oct 28, 2026
First published
Last updated on SAM.gov

Identifiers

Notice ID
33f918c6716e4e99852469db864962f0

Description

The Section on Medicinal Chemistry (SMC) develops new molecular entities with implications in improving health and treatment for various metabolic and alcohol associated diseases. To assess the translational potential of novel molecular entities, which would allow us to make decisions to proceed the compounds for further development we utilize multiple derisking assays. These assays comprise of both cell-based (in vitro) testing and then eventually in mice to assess pharmacokinetic parameters to see if the drug is orally available. 

Request to procure Chemical Reagent (Assay) Development & Laboratory Testing Service SMC to produce grouped ADME assays and perform a Pharmacokinetic study in C57BL6 mice. By including the Caco-2 Permeability Assay in our ADME evaluation it'll accurately predict the oral absorption potential of our compounds. This well-established in vitro model closely mimics the human intestinal epithelium, providing critical insights into a compound’s passive diffusion, active transport, and efflux processes, such as those mediated by P-glycoprotein (P-gp). The data generated from this assay are vital for informing structure-activity relationship (SAR) optimization, improving compound permeability, and reducing transporter-related liabilities that could hinder bioavailability

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Contracting Officer

Primary Contact

Vishnuvajjala Hanumanth Rao

Documents

Files (1)

  • SOW ENAMINE US INC.pdf

    254 KBAdded in Combined Synopsis/Solicitation version 1Posted
    Download

Lifecycle

  1. 1
    Version 1Combined Synopsis/SolicitationArchived

    Assay Service for assessing ADME properties and in vivo PK properties with the selected vendor. ENAMINE US INC

    Notice cda237d603a841e58a64dfcb661f51e2 on SAM.gov

  2. 2
    Version 2Combined Synopsis/SolicitationCancelledArchivedCurrent

    Assay Service for assessing ADME properties and in vivo PK properties with the selected vendor. ENAMINE US INC

    Notice 33f918c6716e4e99852469db864962f0 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

75N98026Q01193ENAMINEUSINCPCANIAAA08396

Archive Date

Sep 20, 2026

Office Address

BETHESDA, MD, 20892